CaMKII, ‘jack of all trades’ in inflammation during cardiac ischemia/reperfusion injury

Wenjia Zhang,Erdan Dong,Junxia Zhang,Yan Zhang
DOI: https://doi.org/10.1016/j.yjmcc.2023.10.003
IF: 5.763
2023-11-01
Journal of Molecular and Cellular Cardiology
Abstract:Myocardial infarction and revascularization cause cardiac ischemia/reperfusion (I/R) injury featuring cardiomyocyte death and inflammation. The Ca<sup>2+</sup>/calmodulin dependent protein kinase II (CaMKII) family are serine/ threonine protein kinases that are involved in I/R injury. CaMKII exists in four different isoforms, α, β, γ, and δ. In the heart, CaMKII-δ is the predominant isoform,with multiple splicing variants, such as δB, δC and δ9. During I/R, elevated intracellular Ca<sup>2+</sup> concentrations and reactive oxygen species activate CaMKII. In this review, we summarized the regulation and function of CaMKII in multiple cell types including cardiomyocytes, endothelial cells, and macrophages during I/R. We conclude that CaMKII mediates inflammation in the microenvironment of the myocardium, resulting in cell dysfunction, elevated inflammation, and cell death. However, different CaMKII-δ variants exhibit distinct or even opposite functions. Therefore, reagents/approaches that selectively target specific CaMKII isoforms and variants are needed for evaluating and counteracting the exact role of CaMKII in I/R injury and developing effective treatments against I/R injury.
cardiac & cardiovascular systems,cell biology
What problem does this paper attempt to address?